THE TOP NEWS IN MARIJUANA LAW REFORM — Volume 27, Issue 26
Show your pride with NORML's Coming Out Green collection
 
NORML News of the Week
 

THE TOP NEWS IN MARIJUANA LAW REFORM

Volume 27   •   Issue 26   •   June 27, 2024

Study: Older Patients Respond Favorably to Medical Cannabis Products

Study: Older Patients Respond Favorably to Medical Cannabis Products

Investigators concluded: "There were consistent improvements across measures of general health and well-being after three months of treatment."

 
Analysis: Proximity to Cannabis Retailers Associated With Rising Home Values

Analysis: Proximity to Cannabis Retailers Associated With Rising Home Values

Homes located in towns with dispensaries experienced, on average, an annual increase in home values of $4,400.

 
 

LATEST NEWS

 
 
Tell the DEA That Cannabis Doesn’t Belong in Schedule I

Submit Your Marijuana Rescheduling Comments to the DEA

The DEA is accepting public comments through July 22. NORML's guide will help you easily prepare and submit yours.

 
 

ACTION ALERTS

 
 
Clinical Trial: Oral CBD Safe and Effective at Treating Anxiety

Clinical Trial: Oral CBD Safe and Effective at Treating Anxiety

The oral administration of CBD "showed therapeutic efficacy, excellent safety, and tolerability."

 
Cannabis Terpenes Exhibit Anti-Cancer Effects in Preclinical Trial

Cannabis Terpenes Exhibit Anti-Cancer Effects in Preclinical Trial

The cannabis terpenes β-caryophyllene and α-humulene reduced neuropathic pain and "significantly inhibited" tumor growth.

 
 

NORML IN THE MEDIA

 
 
Federal Cannabis Action Fund

Prohibitionists have launched a campaign to derail any efforts to remove marijuana from Schedule I. NORML is ready to fight back.

Can you chip in today to help us protect the progress?
 
NORML and The NORML Foundation
1420 K Street, NW, Suite 350
Washington, DC xxxxxx

(202) 483-5500[email protected]
Facebook Twitter Instagram YouTube LinkedIn
Cannabis policy should be evidence-based.
Dispel marijuana myths with the NORML Fact Sheets.

Too many emails? Update your subscription preferences or unsubscribe at the link below.